← Leaderboards
Emmanuel Katsanis
University Of Arizona
$3,797,528
Attributed
$4,727,691
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $630.6K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,727,691 · 3
By mechanism
R01$4,275,441 · 2
R21$452,250 · 1
Top collaborators
- Richard J Simpson3 shared
Most similar at University Of Arizona
Same institution · by research overlap
- Todd W Vanderah$11,756,178
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionIn VivoTumorDendritic CellsIn VitroMolecular ChaperonesBloodCellsLeukemiaResponseT-LymphocyteLymphocyteClinical TrialsPhenotypeImmune ResponseTyrosine Kinase InhibitorVaccinationLaboratoriesPharmaceutical PreparationsImmunizationImmunotherapyGenerationsGrantVaccines
Grant awards (14)
Exercise as an Immune Adjuvant for Gamma Delta T-cell Therapies in Hematologic Malignancies$630,238
R01 · FY2025 · CA
Exercise as an Immune Adjuvant for Gamma Delta T-cell Therapies in Hematologic Malignancies$599,469
R01 · FY2024 · CA
Exercise as an Immune Adjuvant for Gamma Delta T-cell Therapies in Hematologic Malignancies$630,619
R01 · FY2023 · CA
Immunotherapy for Chronic Myelogenous Leukemia$248,905
R01 · FY2013 · CA · contact PI
Immunotherapy for Chronic Myelogenous Leukemia$264,793
R01 · FY2012 · CA · contact PI
Immunotherapy for Chronic Myelogenous Leukemia$264,793
R01 · FY2011 · CA · contact PI
Immunotherapy for Chronic Myelogenous Leukemia$272,983
R01 · FY2010 · CA · contact PI
Immunotherapy for Chronic Myelogenous Leukemia$272,082
R01 · FY2009 · CA · contact PI
(CRCL) vaccine for Chronic Myelogenous Leukemia$264,158
R01 · FY2007 · CA · contact PI
(CRCL) vaccine for Chronic Myelogenous Leukemia$271,748
R01 · FY2006 · CA · contact PI
(CRCL) vaccine for Chronic Myelogenous Leukemia$277,673
R01 · FY2005 · CA
(CRCL) vaccine for Chronic Myelogenous Leukemia$277,980
R01 · FY2004 · CA
Chaperone rich cell lysates (CRCL)Natural adjuvants and*$225,750
R21 · FY2004 · CA
Chaperone rich cell lysates (CRCL)Natural adjuvants and*$226,500
R21 · FY2003 · CA